During the past decade, Hospital Universitario de Getafe conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 21 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 12 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de Getafe" #1 sponsor was "Hospital Universitario Getafe" with 17 trials, followed by "Celgene" with 3 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 3 trials sponsored, "Hospital Universitari Vall d'Hebron Research Institute" with 3 trials sponsored and "Instituto Grifols, S.A." with 3 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Getafe" #1 collaborator was "Hospital Universitario Getafe" with 4 trials as a collaborator, "Apices Soluciones S.L." with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "European Commission" with 2 trials as a collaborator and "Hospital Universitario 12 de Octubre" with 2 trials as a collaborator. Other collaborators include 77 different institutions and companies that were collaborators in the rest 87 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Getafe" are "COVID-19" (5 trials), "Frailty Syndrome" (3 trials), "Multiple Myeloma" (3 trials), "Perioperative Care" (3 trials) and "Peripheral Arterial Disease" (3 trials). Many other conditions were trialed in "Hospital Universitario de Getafe" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Getafe" are "Drug" (61 trials), "Other" (15 trials), "Biological" (10 trials), "Device" (7 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Baricitinib" (2 trials), "Bosentan" (2 trials), "Dexamethasone" (2 trials) and "Lanabecestat" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Getafe" are 96 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario de Getafe". 1 are not yet recruiting, 14 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Hospital Universitario de Getafe, 2 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Getafe, 5 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 8 trials that are defined as “Not Applicable".

Hospital Universitario de Getafe has several departments that took part in Clinical trials: "Intensive Care Unit, Hospital Universitario de Getafe" - 2 trials